ACTRN12605000735651CompletedNot Applicable
The BNP Assisted Teatment to Lessen Serial Cardiac Readmissions and Death.
Health Research Council of New Zealand0 sites363 target enrollmentStarted: November 11, 2005Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 363
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomised controlled trial
- Primary Purpose
- Treatment
- Masking
- Blinded (masking used)
Eligibility Criteria
- Ages
- 18 Years to ot stated (—)
- Sex
- All
Inclusion Criteria
- •Symptomatic congestive HF as defined by Framingham criteria (Table 1), requiring admission to hospital in subjects able to give competent informed consent.
Exclusion Criteria
- •Active myocarditis/pericarditis.Under active consideration for cardiac transplantation. Life expectancy due to non-cardiovascular disease <24 months.Severe hepatic or pulmonary disease (FEV1 <1L).Renal impairment with creatinine at discharge from index admission >0.25mmol/L.Transient HF in association with myocardial infarction treated with acute revascularisation and subsequent ejection fraction during index admission >40%.Severe valvular disease being considered for surgery, or severe aortic stenosis (valve area <1cm2), or symptoms of HF secondary to mitral stenosis.
Investigators
Similar Trials
Completed
Phase 4
T-proBNP Selected PreventiOn of cardiac eveNts in a populaTion of dIabetic patients without A history of Cardiac disease a prospective randomized trial<br>diabetes cardiac disease10012653diabetes mellitusNL-OMON47526Medical university of Vienna200
Active, not recruiting
Phase 1
Prevention of heart disorders in diabetic patients on the basis of NT-proBNP values.EUCTR2015-000239-34-NLMedizinische Universität Wien2,400
Active, not recruiting
Phase 1
Prevention of heart disorders in diabetic patients on the basis of NT-proBNP values.EUCTR2015-000239-34-ATMedizinische Universität Wien2,400
Active, not recruiting
Phase 1
Prevention of heart disorders in diabetic patients on the basis of NT-proBNP values.EUCTR2015-000239-34-ESMedizinische Universität Wien2,400
Active, not recruiting
Phase 1
A clinical study to investigate the use of commonly used heart failure medicines in the prevention of heart related illnesses in patients with diabetes mellitus but without heart disease.EUCTR2015-000239-34-GBMedical University of Vienna2,400